Koyfin Home > Directory > Health Care > Adma Biologics > Net Income Margin

Adma Biologics Net Income Margin Chart (ADMA)

Adma Biologics annual/quarterly Net Income Margin from 2011 to 2020. Net profit margin, or net margin, is equal to net income or profits divided by total revenue and represents how much profit each dollar of sales generates. Net profit margin is the ratio of net profits or net income to revenues for a company.
  • Adma Biologics Net Income Margin for the quarter ending June 06, 2020 was $-259m a 38.88% decrease of -101m year over year
  • Adma Biologics Net Income Margin for the last 12 months ending June 06, 2020 was $-165m a -58.23% increase of 96m year over year
  • Adma Biologics Annual Net Income Margin for 2019 was $-165m a -135.30% increase of 223m from 2018
  • Adma Biologics Annual Net Income Margin for 2018 was $-387m a 28.27% decrease of -109m from 2017
  • Adma Biologics Annual Net Income Margin for 2017 was $-278m a 34.07% decrease of -95m from 2016
Other Margins & Efficiency Metrics:
  • Adma Biologics EBITDA Margin for the quarter ending June 06, 2018 was $-270m a 24.55% decrease of -66m year over year
  • Adma Biologics Return on Capital % for the quarter ending September 09, 2018 was -40.32 a 8.20% decrease of -3.30 year over year
  • Adma Biologics Return on Equity % for the quarter ending September 09, 2018 was -136.10 a -43.11% increase of 58.67 year over year
View Chart On Koyfin

Quarterly ADMA Net Income Margin Data

06/2020$-259m
03/2020$-189m
12/2019$-88m
09/2019$-158m
06/2019$-201m
03/2019$-370m
12/2018$-445m
09/2018$-358m
06/2018$-317m
03/2018$-441m

Annual ADMA Net Income Margin Data

2019$-165m
2018$-387m
2017$-278m
2016$-183m
2015$-250m
2014$-284m
2013$-506m
2012$-653m
2011$-776m